3651 results for «301»
3651 results
Randomised trials: substudies and extended follow-up - A quick update
15 May 2024 – From EuroPCR 2024
This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...
Valve-in-valve: utility of splitting devices
15 May 2024 – From EuroPCR 2024
This session focuses on the use of specialized splitting devices for transcatheter aortic valve-in-valve procedures. It features a case series demonstrating the application of a dedicated splitting device in failed TAVI valves, as well as the use of the BASILICA technique for transcatheter aortic valve replacement....
Devices in pulmonary embolism - Why you should be interested!
15 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of device-based pulmonary embolism treatment. Experts will discuss the clinical problem of pulmonary embolism, the importance of forming a dedicated team, and the available devices and their characteristics. The session will also feature case-based discussions on the use of catheter-directed...
Management of patient with coronary artery disease and left ventricle dysfunction
15 May 2024 – From EuroPCR 2024
This session focuses on the management of patients with stable coronary artery disease and left ventricular dysfunction. Experts will discuss the role of mechanical circulatory support devices in these patients, as well as the diagnosis and treatment of microvascular angina, which can be a challenging complication...
Nightmare cases
15 May 2024 – From EuroPCR 2024
TAVI - Step by step
16 May 2024 – From EuroPCR 2024
This interactive session provides a step-by-step guide on performing minimalist TAVI procedures. Attendees will learn how to optimize TAVI for speed and safety, with a deep dive on the safest techniques for large-bore arterial access and vessel closure. Key topics include femoral access, fluoroscopic projections, crossing...
PCI to treat the bystander disease in STEMI patients: who, when and how?
16 May 2024 – From EuroPCR 2024
Watch this case-based session on PCI for STEMI to see how the guidelines are influenced by the COMPLETE trial. Learn why and how physiology can guide intermediate lesions, the importance of intracoronary imaging guidance, the value of complete revascularization in STEMI patients, the optimal method for...
Intracoronary imaging to guide management in ACS
16 May 2024 – From EuroPCR 2024
This session focuses on the role of intracoronary imaging, specifically IVUS and OCT, in the management of Acute Coronary Syndrome (ACS). Participants will learn when intracoronary imaging can facilitate diagnosis and guide PCI, as well as discuss image interpretation in the setting of ACS.
The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy
17 Sep 2022
Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.
Author
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
